Glaxo SmithKline to close plant.
Drug maker GlaxoSmithKline PLC said it will close its plant in
Cidra, opened in 196, due to declining sales of drugs including the
diabetes treatment Avandia, reports AP (Oct. 24, 2007). The company will
transfer production of Avandia and the related drug Avandamet to other
facilities and reduce its work force in Cidra from 900 to about 250 by
the end of this year, said Stef Mendell, a Raleigh, N.C.-based
spokeswoman for the London-based company. Avandia sales were hurt by a
New England Journal of Medicine article in May that said it raised the
risk of heart attack by 43%. The FDA ruled in July that Avandia could
remain on the market.